News - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News


Pharmaceutical Technology Europe


News bites

Tablet sticking research

Research is being carried out by I Holland and the UK's University of Nottingham in an attempt to combat the problem of tablet sticking. The project, Tabletting Science Anti-stick Research, will use sticky excipients and APIs to analyse why one coating prevents sticking where another does not.
http://PharmTech.com/Sticking

FDA lawsuit dismissed

A US court has denied AstraZeneca's request for a preliminary injunction against FDA. AstraZeneca filed the lawsuit in March with regards to the antipsychotic medicines Seroquel (quetiapine fumarate) and Seroquel XR, seeking to prevent FDA from granting final marketing approval to a generic version of quetiapine until December 2012.
http://PharmTech.com/dismissed

GSK's biopharma boost

GlaxoSmithKline will build a new biopharmaceutical manufacturing facility in the UK — the first in the country in almost forty years. In addition, the company will invest approximately 600 million at other facilities in the UK to increase production of key APIs. The investments are one of the largest commitments to the UK life-sciences sector in recent years.
http://PharmTech.com/biopharmaboost

Ben Venue's review results

The EMA has recommended that manufacturing processes for two anticancer medicines be transferred from Ben Venue Laboratories to alternative facilities. The decision follows GMP shortcomings identified at the US-based manufacturer in late 2011, and marks the end of the EMA's review of medicines produced at the site.
http://PharmTech.com/benvenue


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology Europe,
Click here